Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Morgan Stanley analyst Patrick Wood downgraded the rating for Glaukos Corporation GKOS from Equal-Weight to Underweight and announced a $120 price target. Glaukos shares closed at $143.65 on Friday. See how other analysts view this stock.
- TD Cowen analyst Andrew Kligerman downgraded Markel Group Inc. MKL from Buy to Hold and lowered the price target from $1,986 to $1,836. Markel Group shares closed at $1,782.92 on Friday. See how other analysts view this stock.
- Guggenheim analyst Robert Drbul downgraded the rating for Kohl’s Corporation KSS from Buy to Neutral. Kohl’s shares closed at $14.97 on Friday. See how other analysts view this stock.
- Goldman Sachs analyst Will Nance downgraded Toast, Inc TOST from Buy to Neutral but raised the price target from $34 to $45. Toast shares closed at $43.54 on Friday. See how other analysts view this stock.
- Chardan Capital analyst Daniil Gataulin downgraded Outlook Therapeutics, Inc. OTLK from Buy to Neutral. Outlook Therapeutics shares closed at $2.05 on Friday. See how other analysts view this stock.
Considering buying KSS stock? Here’s what analysts think:
Today's Best Finance Deals
Read This Next:
Loading...
Loading...
GKOSGlaukos Corp
$97.60-%
Edge Rankings
Momentum
20.03
Growth
32.85
Quality
Not Available
Value
20.06
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
